Section Arrow
ENOV.NYSE
- Enovis Corp
Quotes are at least 15-min delayed:2025/02/23 04:01 EST
Last
 42.71
-1.19 (-2.71%)
Day High 
44.03 
Prev. Close
43.9 
1-M High
49.38 
Volume 
458.73K 
Bid
17.13
Ask
67.83
Day Low
42.38 
Open
43.85 
1-M Low
42.91 
Market Cap 
2.50B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 44.14 
20-SMA 45.61 
50-SMA 45.35 
52-W High 63.96 
52-W Low 38.27 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
-2.17/3.76
Enterprise Value
3.01B
Balance Sheet
Book Value Per Share
58.57
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
1.71B
Operating Revenue Per Share
29.21
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BURUNuburu Inc.0.288+0.0879+43.93%-- 
RRRichtech Robotics2.215-0.255-10.32%-- 
SMRNuScale Power Corp19.04-1.74-8.37%-- 
BLDPBallard Power Systems1.4-0.06-4.11%-- 
SERVServe Robotics12.01-1.09-8.32%-- 
Quotes are at least 15-min delayed:2025/02/23 04:01 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.